Alzamend Neuro, Inc. (ALZN)

NASDAQ: ALZN · IEX Real-Time Price · USD
0.670
-0.010 (-1.43%)
At close: Feb 7, 2023, 3:59 PM
0.690
+0.020 (2.97%)
After-hours: Feb 7, 2023, 5:48 PM EST

Income Statement (Annual)

Millions USD. Fiscal year is May - Apr.
Year 2022202120202019
Selling, General & Admin
7.123.643.351.31
Research & Development
5.21.311.073.7
Operating Expenses
12.324.954.425.01
Operating Income
-12.32-4.95-4.42-5.01
Interest Expense / Income
0.050.1600
Other Expense / Income
-0-0.06-0.01-0.15
Pretax Income
-12.36-5.05-4.41-4.86
Net Income
-12.36-5.05-4.41-4.86
Shares Outstanding (Basic)
89737159
Shares Outstanding (Diluted)
89737159
Shares Change
22.64%1.96%21.09%-
EPS (Basic)
-0.14-0.07-0.06-0.08
EPS (Diluted)
-0.14-0.07-0.06-0.08
Free Cash Flow Per Share
-0.07-0.04-0.03-0.02
EBITDA
-12.31-4.89-4.41-4.86
Depreciation & Amortization
0000
EBIT
-12.32-4.89-4.41-4.86
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).